-

Sapio Sciences and CREO Announce Strategic Partnership

Sapio Sciences and CREO to streamline laboratory management and digitally transform life science research

BALTIMORE--(BUSINESS WIRE)--Sapio Sciences, the science-aware™ lab informatics platform, today announced a new strategic partnership with CREO, the preferred consultancy to the world’s most promising companies that seek to improve human health, to deliver comprehensive, end-to-end laboratory information management solutions.

This collaboration combines CREO's digital transformation, validation, and operational management expertise with Sapio Sciences' configurable lab informatics platform, LIMS, Electronic Lab Notebook, and Scientific Data Solutions.

By streamlining operations and increasing team collaboration and productivity, Sapio and CREO aim to accelerate science in research, clinical and molecular diagnostics, and manufacturing environments. This close collaboration will allow life sciences laboratories to navigate complex digital transformation journeys, from initial strategy to day-to-day management and continuous improvement.

“Seamless scientific workflow is at the heart of accelerating today’s medical breakthroughs,” said Connie Pearcy, CREO’s Senior Managing Director of Digital Transformation. “When life sciences laboratories adopt integrated, data-driven solutions deeply aligned to their unique productivity and compliance requirements, they grow more effectively. By leveraging CREO's strategic advisory and IT operational capabilities alongside Sapio's innovative informatics platform, organizations can unlock new forms of operational excellence that empower their scientists to spend more time delivering world-class science.”

Andrew Wyatt, Chief Growth Officer of Sapio Sciences, added: “CREO and Sapio have a shared vision of making life easier for scientists and better for everyone. This partnership will transform research and accelerate drug discovery by giving scientists access to best practice consulting from CREO and the most advanced lab informatics technology from Sapio.”

For more information about the Sapio Partner Program, visit https://www.sapiosciences.com/sspp-partner-program-sapio-sciences/

About Sapio Sciences

Sapio Sciences' mission is to improve lives by accelerating discovery, and because science is complex, Sapio makes technology simple. Sapio is a global business offering an all-in-one science-aware™ lab informatics platform combining cloud-based LIMS, ELN, and Jarvis data solutions.

Sapio serves some of the largest global and specialist brands, including biopharma, CRO/CDMOs and clinical diagnostic labs across NGS genomic sequencing, bioanalysis, bioprocessing, chemistry, stability, histopathology, and in vivo studies.

Customers love Sapio's platform because it is robust, scalable, and with no-code configuration, can quickly adapt to meet unique needs.

For more information, visit www.sapiosciences.com and follow us on LinkedIn.

About CREO

CREO is the preferred consultancy to the world’s most promising companies that seek to improve human health. CREO serves growing life sciences, healthcare, and private equity portfolio companies across the U.S. and international markets. The company’s expertise and knowledge in strategy, M&A, commercialization, digital transformation, cybersecurity, analytics, and quality & regulatory compliance help organizations improve today’s business performance and develop tomorrow’s clinical innovations. Founded in 2015, CREO is headquartered in North Carolina’s Research Triangle Park. Join us and together let’s make a meaningful difference.

Visit CREO at www.creoconsulting.com and follow on LinkedIn.

Contacts

Zyme Communications
Anna Bakewell
Tel: +44 (0)7801 098 242
Email: anna.bakewell@zymecommunications.com

Tim Brook
Head of PR, Sapio Sciences
Tel: +44 (0)7760 766 213
Email: press@sapiosciences.com

Sapio Sciences


Release Versions

Contacts

Zyme Communications
Anna Bakewell
Tel: +44 (0)7801 098 242
Email: anna.bakewell@zymecommunications.com

Tim Brook
Head of PR, Sapio Sciences
Tel: +44 (0)7760 766 213
Email: press@sapiosciences.com

More News From Sapio Sciences

Sapio Sciences Appoints Gordon McCall as Chief Operating Officer to Drive Global Operational Excellence

BALTIMORE--(BUSINESS WIRE)--Sapio Sciences, the science-aware™ lab informatics platform, today announced the promotion of Gordon McCall to Chief Operating Officer (COO). McCall has served as the company’s Chief Financial Officer (CFO) since 2022 and brings a proven track record of leadership, strategic execution, and operational acumen. As COO, McCall will oversee the implementation of Sapio’s day-to-day operations, including leading global customer delivery teams, managing customer relationshi...

Sapio Sciences Introduces Biorepository Management Solution in Sapio Release 25.4

BALTIMORE--(BUSINESS WIRE)--Sapio Sciences, the science-aware™ lab informatics platform, today announced Sapio Release 25.4, introducing a new Biorepository Management solution, enhanced sample management capabilities, and platform-wide enhancements designed to streamline lab operations and support high-throughput research environments. New Biorepository Management Solution The new Sapio Biorepository solution gives labs centralized, flexible management of biospecimens across multiple sites. De...

Sapio Sciences Makes AI-Native Drug Discovery Seamless with NVIDIA BioNeMo

BALTIMORE--(BUSINESS WIRE)--Sapio Sciences, the science-aware™ lab informatics platform, today announced the integration of the NVIDIA BioNeMo platform into the Sapio Lab Informatics Platform. This integration brings AI-driven computational drug discovery directly into Sapio ELN (Electronic Lab Notebook), helping to streamline workflows and improve decision-making in drug discovery. With the BioNeMo platform, researchers can accelerate drug discovery by leveraging science-specific AI frameworks...
Back to Newsroom